Mentice AB (publ) (MNTC.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 16.00 (+0.00%) as of
Key statistics
- Market cap
- 450.01M
- Forward P/E
- 23.19
- EPS (TTM)
- -0.17
- Dividend yield
- 0.00%
- 52-week range
- 9.34 – 18.95
- Beta
- 0.46
- Revenue (TTM)
- 303.12M
- Profit margin
- -1.52%
- Analyst target
- SEK 22.75
- Volume
- 15.94k
About Mentice AB (publ)
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, extensions and add-ons, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Right Heart Cath app, a mobile solution for interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; research and development services; and professional support services for installation, training, and warranty services. It operates in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Gothenburg, Sweden
- Employees
- 109
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.